Cargando…
C(1) inhibitor in canine intravascular hemolysis (C(1)INCH): study protocol for a randomized controlled trial
BACKGROUND: Immune-mediated hemolytic anemia (IMHA) is a common disease that affects all breeds of dogs and is associated with significant morbidity and mortality. Intravascular hemolysis of erythrocytes in IMHA is caused by complement activation and is often fatal. No current treatments target comp...
Autores principales: | Goggs, Robert, Behling-Kelly, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937664/ https://www.ncbi.nlm.nih.gov/pubmed/31888626 http://dx.doi.org/10.1186/s12917-019-2220-2 |
Ejemplares similares
-
In vitro Inhibition of Canine Complement‐Mediated Hemolysis
por: Hernandez, D.M., et al.
Publicado: (2017) -
Comparing the effectiveness of the 0.018-inch versus the 0.022-inch bracket slot system in orthodontic treatment: study protocol for a randomized controlled trial
por: El-Angbawi, Ahmed MF, et al.
Publicado: (2014) -
The INCH-Trial: a multicentre randomized controlled trial comparing the efficacy of conventional open surgery and laparoscopic surgery for incisional hernia repair
por: Poelman, Marijn, et al.
Publicado: (2013) -
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial
por: van Erp, Inge A. M., et al.
Publicado: (2021) -
The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial
por: Heeres, Marjolein, et al.
Publicado: (2011)